Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases

Journal of Rheumatology

Volumn 24, Issue SUPPL. 48, 1997, Pages 13-18

  Marmont, Alberto M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Bone marrow; Rheumatic disease; Stem cell; Transplant

Indexed keywords

ADJUVANT ARTHRITIS; ADOPTIVE IMMUNOTHERAPY; ALLERGIC ENCEPHALITIS; ALLOTRANSPLANTATION; AUTOIMMUNITY; AUTOTRANSPLANTATION; CONFERENCE PAPER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LUPUS ERYTHEMATOSUS; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; THERAPY; ADULT; ANIMAL; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CASE REPORT; DISEASE MODEL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; METHODOLOGY; MOUSE; PATHOPHYSIOLOGY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; ANIMALS; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; RHEUMATIC DISEASES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0030918928     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Rose NR, Bona C: Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993;14:426-30.
2. Marmont AM: Defining criteria for autoimmune diseases (letter). Immunol Today 1994;15:388.
3. Urowitz MB, Gladman DD: Late mortality in SLE: The price we pay for control. J Rheumatol 1980;7:412-6.
4. Snaith ML: The therapy of autoimmunity. In: Isenberg DA, Horfall AC, eds. Autoimmune Diseases. Focus on Sjögren's syndrome. Oxford: BIOS Scientific, 1994:205-16.
5. Cash JM, Wilder RM, eds. Treatment-resistant rheumatic disease. Rheum Dis Clin North America 1995;21:1-270.
6. Bach JF, ed. T-cell directed immune interventions. London-Vienna, Blackwell Scientific, 1993.
7. Adorini L, ed. Selective Immunosuppression: Basic Concepts and Clinical Applications. Basel-Sydney, Karger, 1995.
8. Ikehara S, Inaba M, Yasumizu R, et al: Autoimmune diseases as stem cell disorders. Tohoku J Exp Med 1994;173:141-55.
9. Ikehara S: Intractable diseases and bone marrow transplantation. Pathology Int 1994;44:817-26.
10. Marmont AM: Immune ablation with stem-cell rescue: A possible cure for systemic lupus erythematosus? Lupus 1993;2:151-6.
11. Burt RK, Burns W, Hess A: Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplant 1995;16:1-6.
12. Marmont AM: Immune ablation followed by stem cell rescue: A new radical approach to the treatment of severe autoimmune diseases. Forum Trends Exp Clin Med 1995;5:4-15.
13. Van Bekkum DW: Review: BMT in experimental autoimmune diseases. Bone Marrow Transplant 1993;11:183-7.
14. Marmont AM: Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases? Stem Cells 1994;12:125-35.
15. Marmont AM: Autoimmunity and allogeneic bone marrow transplantation. Bone Marrow Transplant 1992;9:1-3.
16. Marmont AM, Tyndall A, Gratwohl A, Visher T: Haemopoietic precursor-cell transplants for autoimmune diseases. Lancet 1995;345:978.
17. Marmont AM, van Bekkum DW: Stem cell transplantation for severe autoimmune diseases: New proposals but still unanswered questions. Bone Marrow Transplant 1995;16:497-8.
18. Shoenfeld Y, Isenberg D: The Mosaic of Autoimmunity (the factors associated with autoimmune diseases). Amsterdam, Elsevier, 1989.
19. Atkinson JP: Some thoughts on autoimmunity. Arthritis Rheum 1995;38:301-5.
20. Mountz JD, Jianguo W, Jianhua C, Tong Z: Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
21. Talal N: Oncogenes, autogenes, and rheumatic diseases. Arthritis Rheum 1994;31:1421-2.
22. Theophilopoulos AN: The basis of autoimmunity: Part II. Genetic predisposition. Immunol Today 1995;16:150-9.
23. Bernard CCA, Mandel TE, Mackay IR: Experimental models of human autoimmune disease: Overview and prototypes. In: Rose NR, Mackay IR, eds. The Autoimmune Diseases. II. San Diego, Toronto: Academic Press, 1992:47-106.
24. Morton JL, Siegel BV: Transplantation of autoimmune potential. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand black mice. Proc Natl Acad Sci USA 1974;71:2162-6.
25. Denman AM, Russel AS, Denman EJ: Adoptive transfer of the disease of New Zealand black mice to normal mouse strains. Clin Exp Immunol 1969;5:567-70.
26. Van Gelder M: Bone marrow transplantation for treatment of experimental autoimmune encephalomyelitis in rats. Prospects for therapy of severe multiple sclerosis (dissertation). Leiden University, 1995:163.
27. Nishimura M, Toki J, Sugiura K, et al: Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder. J Exp Med 1994;179:1053-8.
28. Ikehara S, Mizutani H, Kurata Y: Autoimmune thrombocytopenic purpura. Crit Rev Oncol Hematol 1995;19:33-45.
29. Adachi Y, Inaba M, Amoh Y, et al: Effect of bone marrow transplantation on antiphospholipid antibody syndrome in murine lupus mice. Immunobiol 1995;192:218-30.
30. Levite M, Zinger H, Mozes E, Reisner Y: Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow derived cells. Bone Marrow Transplant 1993;12:79-183.
31. 1 pre-B cells. J Exp Med 1992;176:1343-53.
32. Blank M, Krause J, Lanir N, et al: Transfer of experimental antiphospholipid syndrome by bone marrow transplantation. The importance of T cell. Arthritis Rheum 1995;38:115-22.
33. Van Gelder M, van Bekkum DW: Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant 1995;16:343-51.
34. Knaan-Shanzer S, Houben P, Kinwel-Bohrè EPM, van Bekkum DW: Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1992;8:333-8.
35. Slavin S: Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: Experimental background and rationale for ABMT. Bone Marrow Transplant 1993;12:201-10.
36. Grau JM, Casademont J, Monforte R, et al: Myasthenia gravis after allogeneic bone marrow transplantation: Report of a new case and pathogenetic considerations. Bone Marrow Transplant 1990;5:435-7.
37. Baldwin JL, Storb R, Thomas ED, Mannik M: Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977;20:1043-8.
38. Jacobs P, Vincent MD, Martell RW: Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anemia. Bone Marrow Transplant 1986;1:237-9.
39. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC: Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993;20:137-40.
40. Mckendry RJR, Huebsch L: Progression of rheumatoid arthritis following bone marrow transplantation. Arthritis Rheum 1996;39:1246-53.
41. Roychowdhury DF, Linker CA: Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. Bone Marrow Transplant 1995;16:471-3.
42. Salzman D, Tami J, Jackson C, et al: Clinical remission of myasthenia gravis (MG) in a patient (PT) after high dose therapy and autologous transplantation with CD34+ stem cells (SC) (abstr). Blood 1994;84:206a.
43. Euler HH, Marmont AM, Bacigalupo A, et al: Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996;88:3621-5.
44. Pelfrey CM, Steinberg AD: Pathogenesis of multisystem autoimmunity-SLE as a model. In: Rose NR, Mackay IR, eds. The Autoimmune Diseases. II. San Diego, Toronto: Academic Press, 1992:107-26.
45. Boyd CN, Ramberg RC, Thomas ED: The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res 1982;6:833-7.
46. Cottler-Fox M, Cipolone K, Yu M, Berenson R, O'Shaughnessy JA, Dunbar C: Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell depletion equivalent to elutriation. Exp Hematol 1995;23:320-2.
47. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, et al: Retrovirally marked CD34+ enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995;85:3048-57.
48. Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ: Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 1994;37:1783-94.